Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design
about
Crystal structure of the stress-inducible human heat shock protein 70 substrate-binding domain in complex with peptide substrateThe G protein α chaperone Ric-8 as a potential therapeutic targetFunctional analysis of Hsp70 inhibitorsStructure of the 34 kDa F-actin-bundling protein ABP34 from Dictyostelium discoideumExploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70.The human HSP70 family of chaperones: where do we stand?Selective targeting of the stress chaperome as a therapeutic strategyAllostery in the Hsp70 chaperone proteinsrDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acidsInvestigating Apoptozole as a Chemical Probe for HSP70 InhibitionBinding of human nucleotide exchange factors to heat shock protein 70 (Hsp70) generates functionally distinct complexes in vitroHsp70 facilitates trans-membrane transport of bacterial ADP-ribosylating toxins into the cytosol of mammalian cells.The Hsp90 machinery facilitates the transport of diphtheria toxin into human cellsA novel Hsp70 inhibitor prevents cell intoxication with the actin ADP-ribosylating Clostridium perfringens iota toxinHSPA8/HSC70 chaperone protein: structure, function, and chemical targeting.A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms.Heat shock protein responses to aging and proteotoxicity in the olfactory bulb.Small molecule DnaK modulators targeting the beta-domain.High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.Integrating surface plasmon resonance biosensor-based interaction kinetic analyses into the lead discovery and optimization process.Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradationHeat shock protein 70 (hsp70) as an emerging drug target.Protein chaperones: a composition of matter review (2008 - 2013).Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.Fear conditioning leads to alteration in specific genes expression in cortical and thalamic neurons that project to the lateral amygdala.Heat shock protein defenses in the neocortex and allocortex of the telencephalon.Heat-induced ribosome pausing triggers mRNA co-translational decay in Arabidopsis thaliana.The Chemical Biology of Molecular Chaperones--Implications for Modulation of ProteostasisHeat shock protein 70 regulates platelet integrin activation, granule secretion and aggregation.A cotranslational ubiquitination pathway for quality control of misfolded proteins.Fluorescent ligand for human progesterone receptor imaging in live cells.The HSP70 family and cancerInhibition of Both Hsp70 Activity and Tau Aggregation in Vitro Best Predicts Tau Lowering Activity of Small Molecules.Comparison of the activity of three different HSP70 inhibitors on apoptosis, cell cycle arrest, autophagy inhibition, and HSP90 inhibition.Pharmacological targeting of the Hsp70 chaperone.A medicinal chemist's guide to molecular interactionsHsp70 protein complexes as drug targets.Heat shock protein 70 inhibitors. 1. 2,5'-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides as irreversible binders to an allosteric site on heat shock protein 70Identification of an allosteric pocket on human hsp70 reveals a mode of inhibition of this therapeutically important protein.Targeting Hsp70: A possible therapy for cancer.
P2860
Q21090602-E982F1BB-A671-4889-AE65-BCB34BB2C997Q26824363-0B2C343E-97F1-458A-81A6-7D4B8DD4F553Q27680671-4612DE53-5C74-4D02-A991-80B8079403E0Q27702044-ADDBE756-6189-4C7D-825A-732DAEA0E012Q27704725-9D3AE092-9080-48C1-8CA5-4071BF10469AQ28071416-B9A38C3B-E9BB-4797-B2F6-E2987E87EBDEQ28248791-A1E37243-02B7-479D-9887-5404610B1653Q28266387-5BF6A497-A1D2-41F3-B4F4-CA988D41B723Q28537716-EF5FCDDB-9B4A-4F9C-BB0B-61E8CCF4F48EQ28550180-926FCAD8-1B13-48F0-8E56-AE7505BE15C6Q28771764-9BFECE8D-8335-4710-92CE-D8B824D2E2EAQ30313128-52656DCC-9713-4282-91B4-E55719857894Q30313276-9812C5D4-E46A-4D8D-B4EA-C406030E0B00Q30315590-CC67762B-D74D-4AB2-A732-42B8E994ACA1Q30354473-85637AF8-EA65-4F85-9363-0084B6E65443Q30372203-0187BE92-8D57-42A9-A1F3-E135E7D6D569Q30382422-B9B70AC2-9001-409F-BE75-375535377494Q33495332-95FDF9A2-F15B-4E27-A852-066B468BBDB7Q33765623-0254780F-0734-440B-80A6-B573EB0BA49DQ33852386-0DF46E09-FB98-45C0-9216-21873F7920FEQ33855062-276D2733-3E65-411D-A42D-8F71DCCBB5D5Q33956906-488991C8-3794-48F4-8107-E8298E3AC537Q34013266-E59033A6-CE37-4FF2-B273-67DD19AAE1BDQ35313148-AF981530-C9E5-44C5-8E82-94461C3C5E1BQ35373330-A5C4439D-BF9F-44AD-9A8A-537797D142A4Q35561538-D94CF0D5-7252-41DE-9BC6-4033DC796BD7Q35562070-442D1753-8A99-448B-A601-32CC0FC6D135Q36059002-ADF085A6-E36F-44FD-B489-6E0D5F17BA19Q36775726-B85971F2-E719-4DA1-9B1B-810FDB84851AQ36844049-93C53E56-BA3B-410A-8DF5-CCB3A63B60E6Q36857601-6971F12C-E986-4F24-8EC2-8850DD4814FDQ36895403-2B4698B2-FB55-45B5-A539-8C5B65E1E675Q37417421-F9B7A8C0-6E31-461C-A8C0-4D257C8B0A0FQ37591467-B8D195E0-23D3-47E6-8490-794330622207Q37622461-2CE76F32-34D9-43E3-9B3D-B06394F2A0D7Q37719514-304EB724-6340-4E03-A8C7-3FE232EF015FQ38037745-A60379A3-721F-42FF-B8B8-1B7B79F91392Q38705756-F305D9AF-E361-46A9-BB70-CE68D5C880B7Q38735132-5138A615-669C-4C37-ADB8-CE7E9944A1CBQ38742944-F000C62A-69DA-4DCA-B459-D6FD84F27E54
P2860
Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Novel adenosine-derived inhibi ...... through structure-based design
@ast
Novel adenosine-derived inhibi ...... through structure-based design
@en
Novel adenosine-derived inhibi ...... through structure-based design
@nl
type
label
Novel adenosine-derived inhibi ...... through structure-based design
@ast
Novel adenosine-derived inhibi ...... through structure-based design
@en
Novel adenosine-derived inhibi ...... through structure-based design
@nl
prefLabel
Novel adenosine-derived inhibi ...... through structure-based design
@ast
Novel adenosine-derived inhibi ...... through structure-based design
@en
Novel adenosine-derived inhibi ...... through structure-based design
@nl
P2093
P50
P3181
P356
P1476
Novel adenosine-derived inhibi ...... through structure-based design
@en
P2093
Alexandra Clay
Allan E Surgenor
Andrew J Massey
Christopher J Graham
Geraint L Francis
James B Murray
Jenifer Borgognoni
Lindsey Terry
Martin J Drysdale
P304
P3181
P356
10.1021/JM801627A
P407
P577
2009-03-01T00:00:00Z